Global Antithrombotic Pressure Pump Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Portable Antithrombotic Pressure Pumps and Stationary Antithrombotic Pressure Pumps), By Application (Hospitals, Ambulatory Surgical Centers, Clinics, Home Care Settings, and Others), By End User (Healthcare Providers, Patients, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Antithrombotic Pressure Pump Market Insights Forecasts to 2035

• The Global Antithrombotic Pressure Pump Market Size Was Estimated at USD 410.5 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 6.73% from 2025 to 2035
• The Worldwide Antithrombotic Pressure Pump Market Size is Expected to Reach USD 840.5 Million by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

According to a research report published by Spherical Insights and Consulting, the global Antithrombotic Pressure Pump market size was worth around USD 410.5 million in 2024 and is predicted to grow to around USD 840.5 million by 2035 with a compound annual growth rate (CAGR) of 6.73% from 2025 and 2035. The market for antithrombotic pressure pump has a number of opportunities to grow due to the growing technological advancements with the development of more effective, easier-to-use, and affordable pumps.

Market Overview

The antithrombotic pressure pump market is the global industry of devices that use cyclical pressure on limbs to prevent blood clots (thrombosis). Antithrombotic pressure pump refers to devices used to help prevent blood clots in the deep veins of the legs. The device uses cuffs around the legs, filling air and squeezing legs, which results in an increase in blood flow through the veins of the legs and aids in preventing blood clots. The emerging cardiovascular disease associated with intravascular thrombosis is a significant health concern, with the influence of a complex interplay of lifestyle, genetic predisposition, and socio-economic factors, leading to the significant demand for antithrombotic pressure pump.

Innovation and market expansion are anticipated as a result of major players' growing R&D expenditures and the expanding partnerships. The increasing integration of advanced technologies in devices is driving a huge surge in the global antithrombotic pressure pump market. For instance, antithrombotic pressure pump SCD600 by COMEN, used for preventing deep vein thrombosis and pulmonary embolism, is integrated with a PID technology, which is a dynamic self-adaptive algorithm for automatic pressure regulation.

Report Coverage

This research report categorizes the antithrombotic pressure pump market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the antithrombotic pressure pump market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the antithrombotic pressure pump market. 

Driving Factors

The market demand for antithrombotic pressure pump is driven by the increased global burden of thrombosis. For instance, deep vein thrombosis is a common venous thromboembolic disorder with an estimated 1.6 cases per 1000 annually. The increasing need for antithrombotic therapy during and after vascular surgery is contributing to driving the market demand. Additionally, the integration of AI-driven diagnostics and predictive analytics that enable more precise patient profiling and real-time monitoring of thrombosis risk is escalating the market growth for antithrombotic pressure pump.

Restraining Factors

The antithrombotic pressure pump market is restricted by the increased cost of advanced antithrombotic pressure pumps, which restricts its adoption in low and middle-income regions. Further, the lack of awareness regarding the device benefits, as well as strict regulatory policies, are challenging the market growth.

Market Segmentation

The antithrombotic pressure pump market share is classified into product type, application, and end user.   

• The portable antithrombotic pressure pumps segment dominated the market in 2024 and is projected to grow at a substantial CAGR of about 7.0% during the forecast period.

Based on the product type, the antithrombotic pressure pump market is divided into portable antithrombotic pressure pumps and stationary antithrombotic pressure pumps. Among these, the portable antithrombotic pressure pumps segment dominated the market in 2024 and is projected to grow at a substantial CAGR of about 7.0% during the forecast period. Portable antithrombotic pumps are lightweight and compact, ideal for home care settings. For instance, Longest, a leading brand from China, introduced portable DVT prevention devices that are a gentle yet effective method aiding in preventing blood clots, featuring adjustable pressure settings, ensuring optimal comfort and therapeutic benefit.

• The hospitals segment accounted for the largest market share of about 58.5% in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the application, the antithrombotic pressure pump market is divided into hospitals, ambulatory surgical centers, clinics, home care settings, and others. Among these, the hospitals segment accounted for the largest market share of about 58.5% in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The expanding hospital networks, along with an increased awareness about thrombotic conditions and increasing healthcare investments, are propelling the segmental market. For instance, in April 2024, GSE extended support to the neurosurgical unit of Korle Bu Teaching Hospital with vital medical equipment donation, which includes two COMEN antithrombotic pressure pumps with reusable garments.

• The healthcare providers segment held the largest market share in 2024 and is anticipated to grow at a significant CAGR of about 5.7% during the forecast period.

Based on the end user, the antithrombotic pressure pump market is divided into healthcare providers, patients, and others. Among these, the healthcare providers segment held the largest market share in 2024 and is anticipated to grow at a significant CAGR of about 5.7% during the forecast period. The segment includes hospitals, clinics, and ASCs, which are the primary purchasers of antithrombotic pressure pumps. Healthcare providers' guide for using DVT pumps for improving patient outcomes, providing customised treatment based on patients’ needs and comfort.

Regional Segment Analysis of the Antithrombotic Pressure Pump Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the antithrombotic pressure pump market over the predicted timeframe.

North America is anticipated to hold the largest share of approximately 42.1% in the antithrombotic pressure pump market over the predicted timeframe. The market ecosystem in North America is strong, due to an increased use of advanced IPC, DVT pumps for hospitals for preventing blood clots formation in patients who are bedridden or have limited mobility. The market for antithrombotic pressure pump has been driven by the region's increased prevalence of thrombotic diseases, healthcare infrastructure, and strong government support. The United States is dominating the market with a major share of nearly 79.9% in the North America antithrombotic pressure pump market, driven by several factors like advancement in medical technology, increasing demand for precise & reliable blood flow management during surgeries, and the trend towards minimally invasive treatments.

Asia Pacific is expected to grow at a rapid CAGR of 8.5% in the antithrombotic pressure pump market during the forecast period. The Asia Pacific area has a thriving market for antithrombotic pressure pump due to its growing healthcare infrastructure, along with an increasing prevalence of thrombotic disorders. Further, the introduction of modern devices like smart technology and portability in antithrombotic pressure pumps is significantly contributing to propel market growth. China is the leading country in the Asia Pacific antithrombotic pressure pump market, with approximately 28.9% share during the forecast period. This is due to the increasing technological innovation and industrial development, promoting economic recovery and green development.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the antithrombotic pressure pump market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Medtronic
• Boston Scientific Corporation
• Abbott Laboratories
• Becton, Dickinson and Company
• Terumo Corporation
• Getinge AB
• Cook Medical
• Cardinal Health
• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
• Smith & Nephew plc
• 3M Company
• Johnson & Johnson
• B. Braun Melsungen AG
• Fresenius Medical Care AG & Co. KGaA
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In October 2023, iElder.asia, sets its sights on the US, Korea, Arab Saudi, Singapore, Brunei, and Australia in its 2024 market expansion strategy, aligning with the evolving e-commerce landscape. Through the company’s e-commerce website, users can compare prices of various elderly care items, book appointments for medical consultations, and purchase supplies.

• In February 2019, the Devon Cirona 6200 DVT pump received FDA approval for its marketing and intended use to help prevent deep vein thrombosis (DVT).

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the antithrombotic pressure pump market based on the below-mentioned segments:  

Global Antithrombotic Pressure Pump Market, By Product Type

• Portable Antithrombotic Pressure Pumps
• Stationary Antithrombotic Pressure Pumps

Global Antithrombotic Pressure Pump Market, By Application

• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Home Care Settings
• Others

Global Antithrombotic Pressure Pump Market, By End User

• Healthcare Providers
• Patients
• Others

Global Antithrombotic Pressure Pump Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa